RECONCILIATION · TERRITORY · COMMISSIONS

Every Device.
Every Case.
Every Dollar.

AI-powered reconciliation and revenue intelligence for medical device sales organizations.

Zuredex automates surgical case sheet reconciliation, purchase order matching, and unresolved revenue detection — giving distributors and sales operations teams the visibility they have never had.

Request DemoSee the Platform
Built in Indiana · Medical device sales operations · Pilot-ready
zuredex · dashboard · morgan hayes · admin
CASES / MONTH
47
TOP MFR: ARTHREX
$103.6K
AT RISK
$19.3K
NEEDS REVIEW
6
ALERT: Jordan Kim · $32.7K at risk · 11 unmatched cases
AR
Alex Rivera
Central Region
92.1%
MATCH
$8.8K
AT RISK
JK
Jordan Kim
Eastern Region
74.4%
MATCH
$32.7K
AT RISK
CN
Casey Nguyen
Northern Region
93.3%
MATCH
$4.2K
AT RISK
FACILITY
SURGEON
PO
STATUS
CONF
Crestview Orthopedic
Dr. N. Calloway
PO-2026-0513
MATCHED
94%
Summit Surgical
Dr. P. Holden
WAITING FOR PO
$4,280
Ridgeline ASC
Dr. M. Wren
PO-2026-0510
MATCHED
97%
Crestview Orthopedic
Dr. N. Calloway
NEEDS REVIEW
$2,840
PRODUCT PREVIEW · SAMPLE DATA · DEMO MEDICAL CO
SIX CAPABILITIES

More than reconciliation.
An operational intelligence platform.

Six capabilities working from the same reconciled data — for operations teams and reps alike.

01
Reconciliation
Automated case-sheet-to-PO matching, with confidence-tiered resolution.
02
Revenue Intelligence
Real-time visibility into reconciled revenue, at-risk cases, and rep performance.
03
Territory Intelligence
Geographic and facility-level visibility into where reps are working and what's being sold.
04
Commission Tracking
Rate-accurate commission calculation across reps, surgeons, and facility agreements.
05
Inventory Analytics
Device and manufacturer-level visibility into what's moving through each territory.
06
Rep Portal
Reps get their own view — case status, pipeline, and performance — not just administrators.
Built for how medical device sales actually works — for operations teams and reps alike.
Secure Cloud Infrastructure
AI-Assisted Validation
Role-Based Access Control
Workflow Audit Logging
Duplicate Prevention
Multi-Tenant Architecture
BUILT ON ENTERPRISE INFRASTRUCTURE
Google CloudBigQueryFirebaseCloud RunPower BI EmbeddedNext.js 16Document AIPython
THE MARKET WINDOW

The infrastructure layer that medical device sales has been missing.

Four forces have created an immediate window for reconciliation automation in this market.

01
Document AI reached production reliability
Parsing surgical PDFs with high confidence is now a solved infrastructure problem.
02
Distributors face margin pressure without visibility
Manual reconciliation leaves untracked revenue in every sales cycle with no systematic way to recover it.
03
Hospital systems are accelerating digitization
Purchase orders and case documentation are increasingly structured and machine-readable.
04
No purpose-built tool exists for this workflow
Generic CRMs and spreadsheets are the current state. There is no reconciliation infrastructure built for device sales.
THE ENGINE

From fragmented documents to
operational intelligence.

Every surgical case generates documents across multiple systems. Zuredex connects them automatically.

DOCUMENT INPUTS
Case Sheets (PDF)
Purchase Orders
Uploaded Documents
Processing Queue
Email Attachments
AI RECONCILIATION ENGINE
Confidence Scoring
Duplicate Detection
Field Normalization
Document Validation
Exception Routing
Audit Logging
OPERATIONAL OUTPUTS
Matched Revenue
Unresolved Alerts
Executive Analytics
Review Queues
Workflow Reports
THE WORKFLOW

See Zuredex in action.

Zuredex processes surgical case sheets, matches them against purchase orders, and surfaces revenue at risk automatically — across the full reconciliation and territory workflow.

Zuredex territory intelligence dashboard with facility drill-down
Sample data shown
OPERATIONAL ANALYTICS

Visibility built around how device sales organizations actually work.

Generic CRMs track relationships.
Zuredex tracks actual surgical revenue.
Revenue by Rep
Revenue by Surgeon
Unresolved Case Exposure
Rep Match Rate
Avg Days to Reconcile
Review Queue Depth
Duplicate Prevention
Monthly Revenue Trend
Alex Rivera92.1%
Jordan Kim74.4%
Casey Nguyen93.3%
$129.8K
Total Reconciled
$19.3K
At Risk
1.4d
Avg Match Time
80.9%
Match Rate
LIVE PRODUCT

Built for the office and the field.

Zuredex admin revenue dashboard
Zuredex mobile dashboard
Zuredex mobile case list
Desktop for operations, mobile for the field · reps get the same real-time visibility wherever they are.
SECURITY & GOVERNANCE

Designed for secure
operational workflows.

Built to minimize PHI exposure and support secure, BAA-governed operational workflows. Zuredex extracts operational and commercial data for reconciliation — patient identifiers are not required for matching and are not extracted into structured records.

RBAC
Role-Based Access Control
Admin, manager, rep, and finance roles with granular permission enforcement.
LOG
Full Audit Trail
Every status change, correction, and review action is logged with timestamp and user attribution.
ISO
Tenant Separation
Organization data is isolated at the query layer. No cross-tenant data access.
ENC
Encrypted Cloud Storage
Documents stored in Google Cloud Storage with encryption at rest and in transit.
SHA
Duplicate Prevention
SHA-256 document fingerprinting prevents duplicate uploads from entering the pipeline.
PHI
PHI-Minimized by Design
Reconciliation runs on operational and commercial fields, not clinical detail. Patient identifiers are not required for matching, and document access is access-controlled and audit-logged.
EARLY ACCESS

Operational intelligence for modern medical device organizations.

Zuredex is preparing pilot deployments for distributors seeking to reduce manual reconciliation and improve revenue visibility.

PILOT-READY · INDIANA-BASED · SEEKING DESIGN PARTNERS
Request DemoSend a Message
WHY WE BUILT THIS

Built in Indiana by Zuredex LLC, informed by firsthand exposure to medical device sales operations, manual PO reconciliation, and rep-level reporting workflows.

— ZUREDEX · INDIANA, USA · 2026